CD4 Therapeutics at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

CD4 Therapeutics at BIO-Europe 2026 in Cologne: 1 session (1 panel discussion).

OrganizationBIO-Europe 2026 Attendance
CD4 Therapeutics
Starnberg, Germany
cd4therapeutics.com
Biotech
Developer of tregalizumab, an antibody that selectively activates regulatory T cells, for autoimmune diseases.
Panel
Tue Nov 10
09:30–09:55
Biopharma Ecosystem Germany: Spotlight on Innovation Drivers Ready for Take-Off
Five teams from Germany's biotech scene, which spans university research, companies, drug manufacturing and healthcare, show their work and its impact.
with Germany Trade & Invest, Rentschler Biopharma, FGK Clinical Research +1 more

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from CD4 Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction